Phase II trial of bortezomib in KRAS G12D mutant lung cancers Meeting Abstract


Authors: Litvak, A. M.; Drilon, A. E.; Rekhtman, N.; Pietanza, M. C.; Chaft, J. E.; Woo, K.; Paik, P. K.; Kris, M. G.; Riely, G. J.
Abstract Title: Phase II trial of bortezomib in KRAS G12D mutant lung cancers
Meeting Title: 51st Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 15 Suppl.
Meeting Dates: 2015 May 29-Jun 2
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-05-20
Language: English
ACCESSION: WOS:000358036903868
PROVIDER: wos
DOI: 10.1200/jco.2015.33.15_suppl.e19002
Notes: Meeting Abstract: e19002 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Natasha Rekhtman
    434 Rekhtman
  2. Maria C Pietanza
    122 Pietanza
  3. Jamie Erin Chaft
    290 Chaft
  4. Gregory J Riely
    604 Riely
  5. Paul K Paik
    256 Paik
  6. Mark Kris
    872 Kris
  7. Alexander Edward Drilon
    636 Drilon
  8. Anna Maria Litvak
    27 Litvak
  9. Kaitlin Marie Woo
    101 Woo